Retail Healthcare Sector

XOMA Royalty

Market Cap: US$321.9m

Operates as a biotech royalty aggregator in the United States and the Asia Pacific.

Cresco Labs

Market Cap: CA$448.7m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

Olema Pharmaceuticals

Market Cap: US$320.9m

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers.

National Research

Market Cap: US$318.5m

Provides analytics and insights that facilitate measurement and improvement of the patient and employee experience.

Pacific Biosciences of California

Market Cap: US$318.1m

Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.

Arcturus Therapeutics Holdings

Market Cap: US$315.7m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

CytomX Therapeutics

Market Cap: US$315.1m

Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.

American Oncology Network

Market Cap: US$314.4m

Through its subsidiaries, provides oncology management services in the United States.

iTeos Therapeutics

Market Cap: US$305.0m

A clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer.

Emergent BioSolutions

Market Cap: US$298.0m

A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.

Alumis

Market Cap: US$291.1m

A clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders.

Compass Therapeutics

Market Cap: US$290.4m

A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.

Entrada Therapeutics

Market Cap: US$286.3m

A clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.

Health Catalyst

Market Cap: US$286.1m

Provides data and analytics technology and services to healthcare organizations in the United States.

Immutep

Market Cap: AU$445.4m

A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.

Imricor Medical Systems

Market Cap: AU$444.7m

A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East.

Heron Therapeutics

Market Cap: US$285.3m

A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.

Healwell AI

Market Cap: CA$397.6m

A healthcare artificial intelligence company, develops and commercializes clinical decision support systems in Canada, New Zealand, Australia, and the United Kingdom.

Neuronetics

Market Cap: US$283.0m

Engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.

Abeona Therapeutics

Market Cap: US$281.0m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Oceania Healthcare

Market Cap: NZ$470.7m

Owns and operates various care centers and retirement villages in New Zealand.

Verano Holdings

Market Cap: CA$388.5m

Operates as a vertically integrated multi-state cannabis operator in the United States.

Neurogene

Market Cap: US$276.3m

A clinical stage biotechnology company, develops genetic medicines for rare neurological diseases.

Sanara MedTech

Market Cap: US$274.5m

A medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States.

Panamera Holdings

Market Cap: US$273.1m

Does not have significant operations.

Cidara Therapeutics

Market Cap: US$272.9m

Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.

Quantum-Si

Market Cap: US$271.6m

A life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).

Aurora Cannabis

Market Cap: CA$379.2m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Cartesian Therapeutics

Market Cap: US$270.7m

A clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases.

SANUWAVE Health

Market Cap: US$267.7m

Operates as a medical device company in the United States and internationally.

aTyr Pharma

Market Cap: US$267.0m

A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.

Viemed Healthcare

Market Cap: US$266.4m

Through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States.

EBR Systems

Market Cap: AU$413.9m

Develops implantable systems for wireless tissue stimulation.

Aura Biosciences

Market Cap: US$260.4m

A clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors.

Candel Therapeutics

Market Cap: US$256.0m

A clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients.

Terns Pharmaceuticals

Market Cap: US$251.5m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.